BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8170946)

  • 1. Fine structure analysis of the WT1 gene in sporadic Wilms tumors.
    Varanasi R; Bardeesy N; Ghahremani M; Petruzzi MJ; Nowak N; Adam MA; Grundy P; Shows TB; Pelletier J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3554-8. PubMed ID: 8170946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.
    Schumacher V; Schneider S; Figge A; Wildhardt G; Harms D; Schmidt D; Weirich A; Ludwig R; Royer-Pokora B
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3972-7. PubMed ID: 9108089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
    Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
    Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
    FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional WT1 mutations in Wilms' tumor patients.
    Diller L; Ghahremani M; Morgan J; Grundy P; Reeves C; Breslow N; Green D; Neuberg D; Pelletier J; Li FP
    J Clin Oncol; 1998 Nov; 16(11):3634-40. PubMed ID: 9817285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
    Waber PG; Chen J; Nisen PD
    Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
    Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
    Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
    Grubb GR; Yun K; Reeve AE; Eccles MR
    Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WT1 splicing alterations in Wilms' tumors.
    Baudry D; Hamelin M; Cabanis MO; Fournet JC; Tournade MF; Sarnacki S; Junien C; Jeanpierre C
    Clin Cancer Res; 2000 Oct; 6(10):3957-65. PubMed ID: 11051244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilms tumor genes.
    Huff V; Saunders GF
    Biochim Biophys Acta; 1993 Dec; 1155(3):295-306. PubMed ID: 8268188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
    Rauscher FJ
    FASEB J; 1993 Jul; 7(10):896-903. PubMed ID: 8393820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.
    Satoh Y; Nakagawachi T; Nakadate H; Kaneko Y; Masaki Z; Mukai T; Soejima H
    J Biochem; 2003 Mar; 133(3):303-8. PubMed ID: 12761165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
    Jiang YP; Shen Y; Sun N; Wang H
    Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.